Unique Industry Case Studies in Iowa City, Iowa

To understand how Iowa City developed into a geographic nexus for highly specialized, R&D-intensive industries, one must trace the region’s historical and institutional evolution. Iowa City was established by an act of the Legislative Assembly of the Iowa Territory on January 21, 1839, serving as the territory’s third capital and eventually the first capital of the State of Iowa until 1857. While the political epicenter of the state eventually relocated to Des Moines, Iowa City retained the state’s flagship academic institution, the University of Iowa (UI), founded in 1847. The early economy of the Iowa City and Coralville area was driven by agrarian needs and the mechanical power of the Iowa River, leading to the establishment of the largest dam in Iowa in 1843 and a subsequent cluster of mills. As the industrial mills eventually closed by the year 1900, the University of Iowa began to assert itself as the primary economic and intellectual engine of the region. Today, the university is a staggering economic powerhouse, adding approximately $8 billion in additional annual value to the state’s coffers, equal to about 4% of the state’s gross domestic product, and supporting one out of every 19 jobs in the state of Iowa.

The transition from a milling and agrarian economy to a high-technology ecosystem was directly facilitated by the University of Iowa’s immense investments in specialized research disciplines. Over the decades, the presence of the UI Hospitals & Clinics, the Carver College of Medicine, and the Iowa Institute of Human Genetics created a fertile environment for biomedical and bioscience research. Similarly, the UI College of Education’s pioneering work in psychometrics birthed the modern educational testing industry, cementing Iowa City’s status as a global hub for educational technology. State and regional economic development groups, such as Greater Iowa City, Inc. and the Iowa Economic Development Authority (IEDA), actively cultivate these industry clusters by fostering synergy between academic research, private capital, and state tax incentives. This deliberate clustering allows companies in biosciences, advanced manufacturing, and technology to benefit from specialized labor pools, shared resources, and knowledge spillovers, directly driving the R&D expenditures that qualify for federal and state tax relief. The following detailed case studies illustrate how specific industries evolved in Iowa City and how their developmental activities satisfy the rigorous thresholds of the United States federal and Iowa state R&D tax credit laws.

Case Study: Bioscience and Custom Nucleic Acid Synthesis

Iowa City’s dominance in the bioscience sector is intrinsically linked to the University of Iowa’s robust medical and biological research programs and a strategic statewide focus on bio-based products and medical innovation. In 2018, a study by TEConomy Partners identified the biosciences as a critical emerging opportunity for Iowa, prompting the creation of BioConnect Iowa to foster commercialization. However, the roots of this industry in Iowa City stretch back decades. In 1987, UI biochemistry professor Dr. Joseph A. Walder utilized foundational technology supported by grants from the National Institutes of Health and the National Science Foundation to launch Integrated DNA Technologies (IDT). The company was incubated at the UI Technology Innovation Center in Coralville through a partnership with Baxter Healthcare Corporation. Over the ensuing decades, IDT evolved from a small startup operating just ten synthesizing machines into the world’s largest manufacturer of custom nucleic acids, synthesizing tens of thousands of custom oligonucleotides daily for a global customer base. The regional access to PhD-level biochemical engineers, combined with strategic acquisitions like Swift Biosciences and Archer RUO assays, solidified the Iowa City area as a global nexus for genomics, synthetic biology, and CRISPR gene editing technologies. In 2018, IDT’s monumental success culminated in its acquisition by the Danaher Corporation for a reported $1.9 billion.

A nucleic acid synthesis company operating in Iowa City fits squarely within the “Life Sciences” and “Bioscience” sectors, making it explicitly eligible for the Iowa R&D tax credit both under the historical rules administered by the Iowa Department of Revenue (IDOR) and the highly restricted 2026 guidelines under Senate File 657. To evaluate federal and state eligibility, consider a hypothetical developmental project where the company seeks to develop a novel enzymatic synthesis platform to assemble complex, double-stranded gene fragments exceeding 3,000 base pairs in length, deliberately avoiding the use of harsh chemical solvents to preserve DNA integrity. This activity initiates a rigorous evaluation under the federal four-part test. First, the company encounters deep technical uncertainty regarding whether their proprietary enzymes can successfully ligate DNA segments at such an extreme length without introducing deletion products or requiring traditional, yield-reducing desalting methods. This satisfies the Section 174 permitted purpose test, as the costs associated with this discovery are inherently experimental. Second, the research fundamentally relies on the hard science principles of biochemistry, molecular biology, and genetics, perfectly satisfying the requirement that the research be technological in nature. Third, the ultimate business objective is the creation of a new, commercially viable clonal DNA construct product intended to be sold to third-party pharmaceutical researchers, satisfying the business component test.

Finally, the company’s research scientists must engage in a rigorous process of experimentation. The scientists formulate specific hypotheses regarding the optimal molar concentrations of the proprietary enzymes and the necessary thermal cycling parameters required to prevent structural degradation. They conduct systematic trial and error, running multiple assay variations in laboratory conditions, and subsequently utilize electrospray ionization mass spectrometry (ESI-MS) to evaluate the purity, sequence verification, and overall yield of the resulting clonal DNA. Pursuant to federal judicial precedent established in the United States Tax Court, even if the foundational science of enzymatic synthesis is broadly understood within the scientific community, the specific application required to scale the production of extreme-length oligonucleotides presents qualifying technical uncertainty. Therefore, the salaries of the research scientists executing the assays, the cost of the biological and chemical reagents consumed during the iterative testing process, and the computational cloud hosting fees incurred while analyzing the complex genomic sequences all qualify as eligible Research and Experimental (R&E) expenditures under United States federal law and Iowa state law.

Case Study: Medical Technology and Targeted Radiopharmaceuticals

The medical technology cluster in Iowa City is anchored by the University of Iowa Hospitals & Clinics (UIHC) and the Carver College of Medicine, institutions possessing a rich, storied history of global medical breakthroughs. These historic milestones include Dr. Ignacio Ponseti’s revolutionary non-surgical method for treating clubfoot, Dr. Elmer L. DeGowin’s foundational developments in modern blood banking, and the installation of the nation’s first BabySIM infant patient simulator. The physical and intellectual infrastructure of the region specifically supports the translation of academic bench research into commercialized medical devices and therapeutics. For instance, facilities like Protostudios, an advanced machining and fabrication laboratory, specialize in developing surgical tools and medical devices, directly responding to the fact that approximately 70% of the intellectual property generated at the University of Iowa relates to health care. Perspective Therapeutics, a radiopharmaceutical development company headquartered at the UI BioVentures Center in Coralville, perfectly exemplifies this trajectory. The company emerged directly from the academic research of Dr. Michael Schultz within the UI radiology department. Perspective Therapeutics is pioneering targeted alpha-particle therapies (TATs) using the radioactive isotope Pb-212. This innovative approach utilizes tumor-specific targeting peptides to deliver powerful, localized radiation directly to cancer cells, effectively eradicating tumors while preventing the severe damage to healthy surrounding tissue that is typically associated with conventional gamma radiation and chemotherapy.

The development of novel cancer therapeutics places this industry within the protected “diagnostic analytics and immunotherapies” and “pharmaceuticals” classifications mandated by the 2026 IEDA certification rules for the Iowa R&D tax credit. To ascertain the applicability of the R&D tax credit, consider a highly complex R&D initiative where the company is attempting to optimize the molecular linker that connects a proprietary lead-chelator to a tumor-specific targeting peptide, specifically designed for a new melanoma treatment such as VMT01. The federal Section 174 test is immediately satisfied because profound technical uncertainty exists regarding the pharmacokinetic stability of the peptide-linker-chelator complex once introduced in vivo. The researchers simply do not know, prior to testing, if the optimized molecule will successfully deliver the alpha-emitting Pb-212 isotope exclusively to the malignant melanoma cells while minimizing systemic toxicity to healthy organs. The research is strictly grounded in the physical and biological sciences, specifically radiochemistry, oncology, and pharmacology, thereby satisfying the technological in nature requirement. Furthermore, the objective is the development of a new, FDA-approved therapeutic drug and complementary imaging diagnostic, satisfying the business component test.

The process of experimentation in the pharmaceutical industry is uniquely rigorous, heavily regulated, and exhaustively documented. The researchers undergo a highly iterative process of designing alternative organic linker molecules, conducting in vitro binding assays, and performing complex animal tissue testing. Ultimately, the experimentation process scales into human clinical trials, where the company must evaluate the toxicity, dosing, and relative efficacy of the radiopharmaceutical across multiple patient cohorts in Phase 1 and Phase 2a trials. The Internal Revenue Service (IRS) Audit Technique Guidelines specifically recognize that designing and conducting clinical trials, testing therapeutic agents, identifying molecular targets, and researching relative efficacy compared to other drugs are definitive examples of qualified research activities within the pharmaceutical industry. Consequently, the wages of the clinical researchers, biostatisticians, and analytical chemists, the specialized supplies and isotopes consumed during the clinical trials, and a statutory percentage of the payments made to independent Contract Research Organizations (CROs) are fully eligible to be claimed as QREs under federal and Iowa law.

Case Study: Educational Technology and Psychometric Software

Iowa City is universally recognized as the historical cradle of the modern educational testing and psychometric assessment industry. In 1929, University of Iowa professor E.F. Lindquist created the Iowa Academic Meet, an initiative that quickly evolved into the globally renowned Iowa Testing Programs. Lindquist revolutionized the entire field of educational measurement in 1955 by inventing the world’s first optical scanner, an engineering breakthrough that allowed standardized tests to be accurately scored by high-speed machinery rather than by tedious manual grading. In 1959, Lindquist utilized this technological foundation to spin off the American College Testing Program, Inc., now globally known as ACT. Today, ACT is an iconic worldwide brand that recently transitioned to a for-profit entity through a partnership with Nexus Capital Management LP, continuing to administer millions of college entrance exams annually from its expansive 93-acre campus in Iowa City. ACT’s massive regional footprint anchors a sprawling “EdTech” cluster in the Iowa City corridor that includes major educational publishers like Pearson, as well as highly innovative software startups such as Pear Deck, College Raptor, and Higher Learning Technologies. A study by TEConomy Partners highlighted that this unique concentration of talent and infrastructure uniquely positions Iowa to capture a massive share of the projected $110 billion global EdTech market.

EdTech software development aligns flawlessly with the “Software and Technology” and “Technology and Innovation” sectors designated for the Iowa R&D tax credit under the strict 2026 IEDA eligibility rules. To illustrate the application of federal tax law to this sector, consider a scenario where an EdTech firm initiates a project to develop a proprietary artificial intelligence (AI) and natural language processing (NLP) algorithm designed to provide rapid, automated scoring for millions of student essays and complex constructed responses. The project is fraught with technical uncertainty, satisfying the Section 174 test, because the engineering team does not know if the NLP model can be trained to accurately decipher complex syntactic structures, detect nuanced human sentiment, and assign scores that statistically correlate with human expert graders without inadvertently introducing demographic or linguistic bias. The development heavily relies on the hard sciences of computer science, data science, and advanced statistical modeling, satisfying the technological in nature requirement. The final algorithmic engine constitutes a new software process that will be fully integrated into the company’s commercial assessment platform, fulfilling the business component test.

The process of experimentation for such software is highly structured. Data scientists and psychometricians design multiple neural network architectures and train these models on massive, anonymized datasets of historical student essays. They systematically tune algorithmic hyperparameters, such as learning rates and dropout layers, and evaluate the automated output against baseline human-scored data. This iterative refinement continues until strict statistical thresholds for validity, reliability, and fairness are achieved, adhering to the complex ethical and technical guidelines set forth by the International Test Commission. Crucially, because this assessment software is integrated into a product that is ultimately sold, leased, or licensed to external third parties (such as school districts or universities), it is legally classified as Non-Internal Use Software (Non-IUS) under Treasury Decision 9786. Consequently, the company is entirely exempt from the burdensome High Threshold of Innovation (HTI) test that typically plagues back-office software claims. This classification ensures that the wages of the software developers, data scientists, and systems analysts dedicated to the NLP project are fully eligible as QREs, generating substantial tax savings.

Case Study: Advanced Manufacturing and Consumer Goods Automation

In addition to its high-tech academic spin-offs, Iowa City boasts a formidable, decades-long legacy in advanced manufacturing, hosting massive production facilities for global legacy brands including Whirlpool, Oral-B, Procter & Gamble (P&G), and CIVCO. Procter & Gamble established its sprawling Iowa City plant in 1956, eventually growing the facility to 311,000 square feet and employing over 600 workers to manufacture health and beauty lines including Head and Shoulders, Herbal Essences, and Old Spice. By the year 2000, however, the plant faced severe existential threats. Product development had been consolidated under the parent company, Braun, forcing the Iowa City workforce to compete for new production lines against facilities in China and Mexico that possessed drastically lower cost structures. Facing imminent closure, the plant’s leadership and workforce aggressively pivoted toward extreme automation, robotics, and lean manufacturing methodologies. By developing a highly automated, proprietary process that integrated plastic molding, complex brush making, and promotional packaging into a single, high-speed continuous flow, and by utilizing rapid kaizen events to drastically reduce machine cycle times, the facility completely reversed its decay in competitiveness. Today, the plant remains a global leader, producing millions of Oral-B power, battery-assisted, and manual toothbrushes daily, and recently secured a massive $150 million expansion investment from P&G.

This sector represents the textbook definition of the “Advanced Manufacturing” classification, a highly protected industry under the historical Iowa RAC and the post-2026 Iowa R&D framework. To analyze R&D eligibility within a modern manufacturing plant, assume the facility’s engineering team initiates a project to completely redesign the automated injection molding process for a new battery-assisted power toothbrush handle that incorporates a novel, sustainable bioplastic resin. The federal Section 174 test is immediately triggered because the plant’s engineers face profound capability and methodology uncertainty. They do not know if the existing high-speed, multi-cavity molds can successfully accommodate the vastly different thermal flow dynamics, cooling rates, and viscosity profiles of the new bioplastic without causing severe manufacturing defects such as warping, flashing, or unacceptable cycle time delays. The project heavily relies on the core principles of mechanical engineering, thermodynamics, and materials science, ensuring it is technological in nature. The desired outcome is a fundamentally improved manufacturing process and a modified physical consumer product, which serves as the required business component.

The engineers must then execute a highly systematic process of experimentation. They begin by utilizing advanced computer-aided design (CAD) software and finite element analysis to model the thermal flow of the resin within the virtual mold cavity. Subsequently, they conduct physical, trial-and-error experimental runs on pilot injection molding machines on the factory floor. They systematically adjust dozens of interconnected mechanical parameters, including extruder barrel temperatures, high-pressure injection speeds, holding pressures, and mold cooling times. After each pilot run, the engineers rigorously evaluate the tensile strength, structural integrity, and aesthetic quality of the resulting handles, iterating the parameters until the defect rate falls within acceptable six-sigma manufacturing tolerances. In this scenario, the time spent by the manufacturing engineers, tooling specialists, and quality assurance technicians conducting these experimental test runs constitutes highly qualified research. However, to avoid the catastrophic documentation failures observed in the Siemer Milling Tax Court case, the manufacturing plant must meticulously record the parameters of each failed test run, the specific mechanical adjustments made in subsequent iterations, and the empirical data proving the presence of systematic trial and error. Provided this documentation exists, the engineering wages and the physical materials destroyed during the pilot runs represent highly lucrative tax credit generation opportunities.

Case Study: Agricultural Technology and Unmanned Aerial Systems

The State of Iowa is the undisputed national leader in the production of corn, pork, eggs, and renewable fuels, rendering the state a natural, expansive laboratory for agricultural innovation. Over the past decade, economic development initiatives such as America’s Cultivation Corridor and the Iowa AgriTech Accelerator have deliberately focused on driving innovation in foodtech and agtech, resulting in a 47% increase in agricultural exports and the generation of over 9,500 patents. Within this massive ecosystem, Iowa City has recently emerged as a focal point for precision agriculture and Unmanned Aerial Systems (UAS) software. Rantizo, a highly innovative AgTech startup, was founded in 2018 in Iowa City by Michael Ott, a University of Iowa chemistry graduate. Rantizo represents the ultimate fusion of Iowa’s deep agrarian roots and cutting-edge high technology. The company became the very first entity approved for drone-based agricultural spraying in multiple Midwestern states, utilizing advanced autonomous flight software to deliver highly precise amounts of liquid fungicides and solid cover crop seeds directly where needed, fundamentally addressing the severe labor shortages plaguing modern agriculture. Supported by a massive Series A funding round led by Leaps by Bayer, Rantizo’s operator network now covers over 30 states, seamlessly integrating drone operations with traditional ground rigs and third-party data analytics platforms.

Under the incredibly stringent 2026 Senate File 657 requirements for the Iowa R&D tax credit, traditional “agriculture production” operations are explicitly excluded from claiming the incentive. However, specialized AgTech software and hardware development operations, such as those conducted by Rantizo, qualify distinctly under the highly protected categories of “Technology and Innovation,” “Software and Technology,” and “Crop Protection”. To evaluate the federal and state tax credit eligibility of such operations, consider a major software development project where the company seeks to develop proprietary “swarming” flight control algorithms. This software is designed to enable a single licensed drone operator to autonomously pilot multiple heavy-lift spray drones simultaneously to apply fungicides across a highly contoured, complex topological field.

The Section 174 test is satisfied immediately, as the engineering team faces immense uncertainty regarding the complex telemetry communication architecture. Furthermore, they must determine how to program highly responsive collision-avoidance algorithms that can process massive streams of real-time topographical and weather data to adjust individual flight paths in milliseconds. The project relies on the hard sciences of computer science, aerospace engineering, and advanced radio telemetry communications, making the research inherently technological in nature. The ultimate development yields a new, integrated software platform and a synchronized hardware control process utilized to execute the company’s commercial spraying services, satisfying the business component test. The software engineers initiate a process of experimentation by writing initial C++ and Python code for the swarming logic. They simulate autonomous flights in highly controlled virtual environments, tracking critical metrics such as data packet loss, latency, and GPS drift. Moving beyond simulations, they conduct live field tests, systematically modifying the algorithms to correct wind-induced drift, optimize rapid battery consumption, and ensure precise, overlapping chemical application mapping. The federal R&D tax credit generously permits the inclusion of wages for the control systems engineers, applications engineers, and network architects developing this code. Crucially, the drones, expensive microchips, and hardware components that are inevitably consumed, damaged, or entirely destroyed during these high-risk experimental test flights can be legally captured as qualified supply expenses, further maximizing the value of the credit.

Detailed Analysis of United States Federal R&D Tax Credit Requirements

The federal Research and Development tax credit, formally known as the Credit for Increasing Research Activities and codified under Section 41 of the Internal Revenue Code (IRC), is widely considered one of the most valuable, yet legally complex, tax incentives available to American businesses. Initially enacted in 1981 as a temporary measure under the Economic Recovery Tax Act, the credit was designed to stimulate domestic corporate investment in technological innovation and prevent the offshoring of critical engineering jobs. After decades of temporary extensions, the credit was finally made permanent by the PATH Act (part of the Consolidated Appropriations Act, 2016), providing businesses with the certainty required to make long-term R&D capital investments. The credit functions by providing a direct, dollar-for-dollar reduction in a taxpayer’s federal income tax liability (and in some cases, payroll tax liability for qualified small businesses), calculated as a percentage of Qualified Research Expenses (QREs) that exceed a historically determined base amount. However, the Internal Revenue Service (IRS) has recently noted that Section 41 is a highly complex area of law, fraught with super-technical statutory definitions, numerous exclusions, and significant computational elements that must be applied to every single research activity claimed by a taxpayer. The United States Tax Court has echoed this sentiment, officially recognizing the research credit as one of the most complicated provisions in the entire Internal Revenue Code.

The Federal Four-Part Test Framework

For any developmental activity or engineering project to be legally deemed “qualified research,” it must simultaneously satisfy all four criteria outlined in IRC §41(d). The burden of proof rests entirely and heavily on the taxpayer to substantiate that these tests are met at the lowest possible level of the business component.

Statutory Exclusions and the Complexity of Software Development

Section 41(d)(4) explicitly lists several types of activities that are categorically excluded from the definition of qualified research, regardless of whether they technically meet the four-part test. The most notable exclusions include research conducted after the beginning of commercial production of the business component, the adaptation of an existing business component to a particular customer’s requirement, reverse engineering of an existing product, routine quality control testing, and routine data collection. Furthermore, research that is deemed “funded” by any grant, contract, or another entity is strictly ineligible. To claim the credit for contract research, the taxpayer must retain substantial rights to the intellectual property being developed and must bear the ultimate economic risk of failure (i.e., payment must be strictly contingent upon the success of the research).

The application of the R&D tax credit to software development introduces a highly scrutinized layer of legal complexity. The IRS, recognizing the ubiquity of software, issued Treasury Decision 9786 in 2016 to establish definitive rules segregating commercial software from Internal Use Software (IUS). The regulations define Internal Use Software as software developed primarily to support the general and administrative functions of a business, specifically identifying three categories: financial management functions, human resource management functions, and support services (such as data processing or facility services).

Judicial Precedent Shaping Federal Eligibility and Documentation

The interpretation of the four-part test, the section 174 requirements, and the necessity of contemporaneous documentation have been rigorously shaped by decades of United States Tax Court decisions. These judicial rulings form the strict operational boundaries within which corporate taxpayers must document, calculate, and defend their R&D claims.

Suder v. Commissioner (T.C. Memo. 2014-201): In the landmark Suder case, the Tax Court evaluated the R&D claims of an electronics telecommunications company. The IRS aggressively argued that because the company’s engineers utilized common, established principles of engineering to solve their problems, there was no true technical uncertainty, and thus no qualified research. The Tax Court decisively sided with the taxpayer, affirming the vital principle that a business does not have to “reinvent the wheel” for its activities to be eligible for the credit. The ruling clarified that the Section 174 uncertainty requirement is legally satisfied even if a business knows that achieving a goal is technically possible at the outset, provided the business is uncertain of the specific method or appropriate design required to successfully reach that goal. Furthermore, the court validated the taxpayer’s methodology of utilizing expert testimony to allocate employee wages to qualified activities.

Siemer Milling Company v. Commissioner (T.C. Memo. 2019-37): Conversely, the Siemer Milling decision serves as a severe and enduring warning regarding the absolute necessity of contemporaneous documentation. The taxpayer, a family-owned wheat milling business, claimed substantial credits for various product and process improvements implemented on their factory floor. The Tax Court completely disallowed 100% of the taxpayer’s claimed credits. The judge ruled that the taxpayer failed to produce sufficient, detailed evidence demonstrating that they actually formulated testable hypotheses, modeled alternative designs, or engaged in any form of systematic trial and error. The ruling cemented the principle that a mere verbal assertion that trial and error occurred is entirely insufficient; the “process of experimentation” must be rigorously documented through physical testing logs, design iteration schematics, and failure analyses. Notably, while the credits were totally denied, the court declined to impose accuracy-related penalties on the taxpayer because they had reasonably relied on the advice of professional tax accountants.

Meyer, Borgman & Johnson, Inc. v. Commissioner (8th Cir. 2024): In a highly impactful recent appellate decision, the United States Court of Appeals for the Eighth Circuit upheld a Tax Court decision denying approximately $190,000 in research credits to a structural engineering firm. The court ruled that the research was legally “funded” under §41(d)(4)(H) because the taxpayer’s right to payment was not truly contingent on the success of the research. The engineering firm argued that their fixed-price contracts required strict adherence to specific building codes, rendering payment practically contingent on successful design execution. Both the Tax Court and the Eighth Circuit firmly disagreed, establishing a remarkably strict legal standard for evaluating economic risk in contract research and highlighting the vital necessity for engineering firms to carefully review the specific indemnification and payment terms of their client contracts before claiming the credit.

Phoenix Design Group, Inc. v. Commissioner (Pending): This ongoing litigation in the Tax Court highlights the IRS’s continued, aggressive scrutiny of the Section 174 statutory definition of costs incurred in the “experimental or laboratory sense”. The taxpayer designs highly complex mechanical, electrical, and plumbing systems for medical laboratories and research facilities. This case underscores the ongoing necessity for taxpayers operating in applied engineering and architectural disciplines to clearly prove that their design work transcends routine engineering practices and enters the realm of true, qualifying experimental development.

Detailed Analysis of Iowa State R&D Tax Credit Requirements and Administration

Historically, the State of Iowa has offered one of the most generous, robust, and heavily utilized R&D tax incentives in the United States, deliberately coupling its state-level definitions of qualified research directly to the federal IRC §41 statutes to encourage seamless compliance. However, the program is currently undergoing a massive, unprecedented legislative transformation, shifting from a broad, calculation-based tax entitlement to a tightly capped, highly regulated economic development grant program.

The Historical Paradigm (Pre-2026 Rules)

Prior to the impending 2026 legislative overhaul, the Iowa Research Activities Credit (RAC) operated as a refundable state tax credit administered directly by the Iowa Department of Revenue (IDOR) under Iowa Code §422.10 and §422.33. The credit was considered highly attractive to corporate taxpayers because it was fully refundable; if the calculated credit amount exceeded a company’s total Iowa corporate income tax liability, the state treasury issued a direct cash refund for the difference, providing immediate liquidity to rapidly growing technology startups operating at a net loss.

To calculate the Iowa RAC, taxpayers were required to file Form IA 128 or IA 128S alongside their state tax returns, choosing between two primary calculation methodologies. The Regular Method offered a highly lucrative 6.5% credit on the excess of Iowa-based QREs over a historically calculated base amount (with the statutory caveat that the base amount could not be less than 50% of the current year’s QREs). Alternatively, taxpayers could elect the Alternative Simplified Credit (ASC) method, which offered a 4.55% rate on excess QREs compared to a rolling average of the prior three years’ expenditures. In unique circumstances, businesses approved under the High Quality Jobs (HQJ) program could claim massive supplemental credits of up to 10%.

In response to skyrocketing claims that reached $77.6 million in a single fiscal year, the Iowa legislature enacted Senate File 2417 in 2018, imposing strict, unprecedented industry limitations on who could legally claim the RAC. To be eligible, a business was forced to meet two new requirements: they had to formally claim and be allowed the federal R&D credit on their IRS return, and they had to operate primarily within one of five narrowly defined industries: Manufacturing, Life Sciences, Software Engineering, Agriscience, or Aviation and Aerospace. The IDOR subsequently issued strict administrative rules explicitly declaring a vast array of businesses completely ineligible, regardless of their actual research activities. These permanently excluded entities included accounting firms, architectural firms, real estate companies, retail operations, and, notably, massive sectors of the Iowa economy such as agricultural production and agricultural cooperatives. Following these industry restrictions, House File 2317 placed severe limitations on the refundability of the credit, stepping down the refundable cash portion incrementally from 100% to 50% by the year 2027, and entirely disallowing the carryforward of any unused refundable credits.

The 2026 Legislative Overhaul (Senate File 657)

In 2025, the Iowa legislature enacted Senate File 657 (the Economic Development Programs and Credits Act), executing a fundamental, structural overhaul of the state’s entire corporate tax incentive landscape. Effective for tax years beginning on or after January 1, 2026, the traditional, entitlement-based Research Activities Credit is permanently repealed and completely replaced by a new, highly regulated “R&D Tax Credit Program”. This legislation transfers absolute administrative control of the credit from the IDOR to the Iowa Economic Development Authority (IEDA), transforming the incentive from a retroactive tax calculation into a highly competitive economic development tool.

Under the draconian new regime, businesses can no longer simply calculate their R&D credits at the end of the tax year and claim them retroactively. Instead, businesses must undergo a mandatory, rigorous pre-application process through an online portal to secure formal IEDA certification as a “qualified business”. Furthermore, because the IEDA is mandated to allocate the strict $40 million pool on a pro-rata basis among all approved applicants, the legislation introduces massive financial uncertainty for long-term corporate tax planning. The most radical compliance shift requires the taxpayer to hire an independent Certified Public Accountant (CPA) to fully review and verify their claimed Qualified Research Expenditures before applying to the IEDA. This unprecedented requirement effectively privatizes the first layer of the tax audit process, shifting an immense financial compliance burden directly onto the shoulders of the innovating businesses.

Strategic Compliance and Audit Preparedness in Iowa City

The shifting regulatory landscape demands proactive tax planning and flawless, contemporaneous documentation from every technology and manufacturing firm operating in the Iowa City corridor. Historically, the Iowa Department of Revenue largely mirrored the IRS in its audit procedures, operating under a formal Taxpayer Bill of Rights (TBOR) and primarily scrutinizing the substantive, scientific nature of the research claimed. As established by the devastating Siemer Milling Tax Court case, government auditors will immediately disqualify claims lacking contemporaneous documentation, such as project charters, iteration logs, and failed test records.

The 2026 implementation of Iowa Senate File 657 fundamentally alters the entire compliance timeline. Starting in 2026, firms in Iowa City must maintain perfect, real-time R&D tracking systems that explicitly link engineering hours to specific projects and technical uncertainties, ensuring the data is robust enough to survive the mandatory, front-end CPA verification process. Furthermore, companies must engage these independent CPAs early in the fiscal year to ensure the verification study is completed prior to the strict January 31 IEDA application deadline. Finally, companies operating on the fringes of explicitly excluded industries—such as an EdTech company that also acts as a traditional textbook publisher—must carefully and legally ring-fence their software development QREs to satisfy the IEDA’s incredibly strict sector mandates and avoid total disqualification.

Final Thoughts

The vast, highly technical innovation ecosystem thriving within Iowa City is a profound testament to the synergistic power of academic research, private enterprise capital, and strategic government incentivization. As clearly demonstrated by the rapid evolution of the bioscience, medical technology, advanced manufacturing, educational technology, and agricultural technology sectors, the developmental activities occurring daily within the region frequently and robustly meet the highest statutory thresholds of the IRC §41 Four-Part Test. The ability to legally offset the massive financial risks inherent in discovering new genomic synthesis methods, targeted radiopharmaceuticals, or autonomous drone swarming algorithms relies entirely on these federal and state tax credits.

However, the impending, radical transition to the 2026 Iowa R&D Tax Credit Program under the authority of the IEDA introduces unprecedented competitive and administrative hurdles. Companies that successfully adapt their internal operations to meet these new CPA verification requirements, master the complex IEDA pre-application mandates, and maintain flawless contemporaneous documentation of their scientific failures and successes will continue to reap significant financial rewards. These incentives will remain vital, effectively subsidizing the financial risks of pushing the boundaries of technological advancement in the heart of the American Midwest.

The information in this study is current as of the date of publication, and is provided for information purposes only. Although we do our absolute best in our attempts to avoid errors, we cannot guarantee that errors are not present in this study. Please contact a Swanson Reed member of staff, or seek independent legal advice to further understand how this information applies to your circumstances.